ENDOMIMETICS LLC

Birmingham, AL · Medtech · Private

Nitric oxide and antibiotic-loaded liposomal coating for knee implants to prevent post-operative infection, inflammation, and arthrofibrosis

endomimetics.com →
Grants
$9.0M
14 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Bionanomatrix coating for brain aneurysm coils to enhance healing$553,378
Federal grantDepartment of Health and Human Services · Phase I · Nitric oxide releasing nanomatrix wrap to enhance dialysis fistula maturation$429,486
Federal grantDepartment of Health and Human Services · Phase II · Nitric oxide releasing nanomatrix to enhance dialysis fistula maturation$972,781
Federal grantDepartment of Health and Human Services · Phase I · Coating to enhance endothelialization after left atrial appendage closure$463,188
Federal grantDepartment of Health and Human Services · Phase II · Nitric oxide releasing nanomatrix to enhance dialysis fistula maturation$940,410
Federal grantDepartment of Health and Human Services · Phase I · Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms$563,196
Federal grantDepartment of Health and Human Services · Phase II · Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation$940,759
Federal grantDepartment of Health and Human Services · Phase I · Dual-action drug coated balloon to mitigate neointimal hyperplasia and promote endothelialization.$497,306
Federal grantDepartment of Health and Human Services · Phase II · Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation$977,762
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Bionanomatrix coating to enhance antibacterial effects while reducing inflammation of knee joint implants$292,643
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Bionanomatrix coating to enhance antibacterial effects while reducing inflammation of knee joint implants$292,643
Federal grantDepartment of Health and Human Services · Phase II · Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms$920,119
Federal grantDepartment of Health and Human Services · Phase I · Atherosclerosis assay development for drug efficacy and cytotoxicity screening$304,119
Federal grantDepartment of Health and Human Services · Phase II · Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms$853,282
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1954Theranos Inc—$627M
1955NOVAFLUX, INC.——
1956Artisight, Inc.——
1957ENDOMIMETICS LLC——
1958SPINEX, INC.——
1959ALLAY THERAPEUTICS INC——
1960LO BIOSCIENCES, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 4
  • Peptide Amphiphiles With Modified Degrading Sequences And Methods Of Use Thereofapplication
  • Peptide Amphiphile Compositions And Methods Of Use Thereofapplication
  • Peptide Amphiphile Compositions And Methods Of Use Thereofapplication
  • Peptide Amphiphiles With Modified Degrading Sequences And Methods Of Use Thereofapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.